Similar articles for PMID: 26811362

Year	Number of Results
1995	1
1996	2
1998	1
2000	1
2001	3
2002	1
2003	1
2008	1
2009	1
2010	1
2013	1
2014	3
2015	23
2016	33
2017	25
2018	16
2019	6
2020	8
2021	9
2022	2
2023	0

1

Bleeding associated with coadministration of rivaroxaban and clarithromycin.

Fralick M, Juurlink DN, Marras T. Fralick M, et al. CMAJ. 2016 Jun 14;188(9):669-672. doi: 10.1503/cmaj.150580. Epub 2016 Jan 25. CMAJ. 2016. PMID: 26811362 Free PMC article. No abstract available.

2

Safety of early initiation of rivaroxaban or dabigatran after thrombolysis in acute ischemic stroke.

Ritzenthaler T, Derex L, Davenas C, Bnouhanna W, Farghali A, Mechtouff L, Cho TH, Nighoghossian N. Ritzenthaler T, et al. Rev Neurol (Paris). 2015 Sep;171(8-9):613-5. doi: 10.1016/j.neurol.2015.02.012. Epub 2015 Apr 7. Rev Neurol (Paris). 2015. PMID: 25857461

3

[Pruritus and rivaroxaban].

Aguilar-Shea AL, Gallardo-Mayo C. Aguilar-Shea AL, et al. Semergen. 2018 May-Jun;44(4):e96-e97. doi: 10.1016/j.semerg.2017.12.007. Epub 2018 Feb 10. Semergen. 2018. PMID: 29439912 Spanish. No abstract available.

4

Evaluation of the Efficacy and Safety of Direct Oral Anticoagulants in Japanese Patients-Analysis of Pharmaceuticals and Medical Devices Agency Data.

Terayama Y. Terayama Y. J Stroke Cerebrovasc Dis. 2017 Jun;26(6):1171-1181. doi: 10.1016/j.jstrokecerebrovasdis.2016.12.035. Epub 2017 Feb 3. J Stroke Cerebrovasc Dis. 2017. PMID: 28169097

5

Indirect antiplatelet effects of rivaroxaban in a patient with intracranial hemorrhage: An underappreciated coagulopathy of factor Xa inhibitors?

Gilbert BW, Tabaka CA. Gilbert BW, et al. Am J Emerg Med. 2022 Jan;51:426.e5-426.e7. doi: 10.1016/j.ajem.2021.06.072. Epub 2021 Jul 2. Am J Emerg Med. 2022. PMID: 34244010

6

Comparison of the Incidence of Major Bleeding With Rivaroxaban Use Among Nonvalvular Atrial Fibrillation Patients With Versus Without Diabetes Mellitus.

Peacock WF, Tamayo S, Sicignano N, Hopf KP, Yuan Z, Patel M. Peacock WF, et al. Am J Cardiol. 2017 Mar 1;119(5):753-759. doi: 10.1016/j.amjcard.2016.11.023. Epub 2016 Dec 9. Am J Cardiol. 2017. PMID: 28081941 Free article.

7

Rivaroxaban (Xarelto) plus aspirin for secondary prevention of cardiovascular events.

[No authors listed] [No authors listed] Med Lett Drugs Ther. 2018 Dec 3;60(1561):196-197. Med Lett Drugs Ther. 2018. PMID: 30653475 No abstract available.

8

Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors.

Connolly SJ, Milling TJ Jr, Eikelboom JW, Gibson CM, Curnutte JT, Gold A, Bronson MD, Lu G, Conley PB, Verhamme P, Schmidt J, Middeldorp S, Cohen AT, Beyer-Westendorf J, Albaladejo P, Lopez-Sendon J, Goodman S, Leeds J, Wiens BL, Siegal DM, Zotova E, Meeks B, Nakamya J, Lim WT, Crowther M; ANNEXA-4 Investigators. Connolly SJ, et al. N Engl J Med. 2016 Sep 22;375(12):1131-41. doi: 10.1056/NEJMoa1607887. Epub 2016 Aug 30. N Engl J Med. 2016. PMID: 27573206 Free PMC article. Clinical Trial.

9

Rivaroxaban for post-discharge thromboprophylaxis: the MARINER trial.

Ramacciotti E, Fareed J. Ramacciotti E, et al. Int Angiol. 2018 Dec;37(6):427-430. doi: 10.23736/S0392-9590.18.04069-5. Int Angiol. 2018. PMID: 30558402 Free article. No abstract available.

10

Rivaroxaban (Xarelto) - a new peripheral artery disease indication.

[No authors listed] [No authors listed] Med Lett Drugs Ther. 2021 Nov 1;63(1636):172-173. Med Lett Drugs Ther. 2021. PMID: 35085206 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed